Albemarle Corp Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $5.1B-4.4% YoYTTM through 31 Dec 2025
Net Income -$510.6MTTM through 31 Dec 2025
Free Cash Flow $692MTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| Gross Margin | 13.0% |
| Operating Margin | -7.1% |
| Net Margin | -9.9% |
Returns
-5.4%ROE
-3.1%ROA
Balance Sheet Health
Debt / Equity0.33x
Current Ratio2.23x
Net Debt$1.6B
Cash & Equivalents$1.6B
Quality Metrics
FCF Margin13.5%
Rule of 4032.9
Earnings-Beat Rate75.0%
Dividend
$0.81Per share, FY20260.69%Yield-12.3%5-yr growth
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Energy Storage | |||
| Ketjen | View detailsOn track to close the sale of a controlling stake in Ketjen in Q1 2026. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.